Skip to main content
OpenTrials

Clinical trial condition

Brenner Tumor

Explore clinical trials studying Brenner Tumor. Study availability and eligibility vary by location and protocol.

39 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Brenner Tumor trial results

Completed

Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer

NCT00003322

Conditions
Adnexal Diseases, Brenner Tumor, Carcinoma, +23 more
Locations
  • University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States
  • CCOP - Greater Phoenix Phoenix, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
View all 67 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

NCT00005026

Conditions
Adnexal Diseases, Brenner Tumor, Carcinoma, +23 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • Community Hospital of Los Gatos Los Gatos, California, United States
  • University of Colorado Cancer Center Denver, Colorado, United States
View all 47 locations
View Trial Details
Completed

Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

NCT00217529

Conditions
Adnexal Diseases, Brenner Tumor, Carcinoma, +26 more
Locations
  • Pacific Gynecology Specialists Seattle, Washington, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
  • University of Washington School of Medicine Seattle, Washington, United States
View Trial Details
Active, Not Recruiting

Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

NCT01167712

Conditions
Adnexal Diseases, Brenner Tumor, Endocrine System Diseases, +50 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
View all 564 locations
View Trial Details
Active, Not Recruiting

Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT02101775

Conditions
Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +33 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Decatur Memorial Hospital Decatur, Illinois, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

NCT00565851

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, +51 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 709 locations
View Trial Details

Related conditions